Serum progesterone and prognosis in operable breast cancer
1996

Serum Progesterone and Prognosis in Operable Breast Cancer

Sample size: 289 publication Evidence: moderate

Author Information

Author(s): PE Mohr, DY Wang, WM Gregory, MA Richards, IS Fentiman

Primary Institution: Guy's Hospital, London

Hypothesis

Does the level of serum progesterone at the time of surgery affect the prognosis of women with operable breast cancer?

Conclusion

Higher levels of progesterone at the time of tumor excision are associated with better survival outcomes in women with operable breast cancer.

Supporting Evidence

  • Women with progesterone levels >4 ng ml-1 had significantly better survival rates.
  • The study included 289 premenopausal women who had blood taken shortly after surgery.
  • Progesterone levels were measured using radioimmunoassay kits.
  • Statistical analysis was performed using Kaplan-Meier and Cox's proportional hazards model.

Takeaway

Women with higher progesterone levels when they have breast cancer surgery tend to live longer than those with lower levels.

Methodology

Blood samples were taken from premenopausal women within 3 days of tumor excision, and progesterone levels were measured to assess their relationship with survival outcomes.

Potential Biases

Potential misclassification of menstrual cycle status due to errors in reporting the last menstrual period.

Limitations

The study relies on self-reported menstrual cycle data, which may lead to misclassification.

Participant Demographics

289 premenopausal women with operable breast cancer treated between 1975 and 1992.

Statistical Information

P-Value

0.01

Confidence Interval

RR=2.22 (1.15-4.29) for node-positive cases with higher progesterone levels.

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication